Safety of Magnetic Resonance Imaging in Patients with Surgically Implanted Permanent Epicardial Leads

Yue-Dong Ma,Ulrika Birgersdotter-Green,Kavisha Patel,Malini Madhavan,Yong-Mei Cha,Robert E. Watson,Nora E. Olson,Siva K. Mulpuru,Abhishek J. Deshmukh,Ammar M. Killu,Paul A. Friedman
DOI: https://doi.org/10.1016/j.hrthm.2023.04.003
IF: 6.779
2023-04-19
Heart Rhythm
Abstract:Background Magnetic resonance imaging (MRI) safety in patients with an epicardial cardiac implantable electronic device (CIED) is uncertain. Objective To assess the safety and adverse effects of MRI in patients who had surgically implanted epicardial CIED. Methods Patients with surgically implanted CIEDs who underwent MRI with an appropriate Cardiology–Radiology collaborative protocol between January 2008 and January 2021 were prospectively studied in two clinical centers. All patients underwent close cardiac monitoring through MRI procedures. Outcomes were compared between the epicardial CIED group and matched the non-MRI-conditional transvenous CIED group. Results Twenty-nine consecutive patients with epicardial CIED (male 41.4%, mean age of 43 years) underwent 52 MRIs in the 57 anatomic regions. Sixteen patients had pacemakers, 9 had cardiac defibrillators or cardiac resynchronization therapy defibrillators, and 4 had no device generators. There were no significant adverse events in epicardial or transvenous CIED groups. The battery life, pacing, sensing thresholds, lead impedance and cardiac biomarkers were not significantly changed, except one patient had a transient decrease in atrial lead sensing function. Conclusion MRI of CIEDs with epicardially implanted leads does not represent a greater risk than the transvenous CIEDs when performed with a multidisciplinary collaborative protocol centered on patient safety.
cardiac & cardiovascular systems
What problem does this paper attempt to address?